Insulin aspart, recombinant Subcutaneous and Selenious Acid
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Selenious Acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: selenium
Brand name: Selenium TR, Selepen, Sele-Pak
Synonyms: Selenium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Selenious Acid Injection
- Insulin aspart, recombinant Subcutaneous-Selenium
- Insulin aspart, recombinant Subcutaneous-Selenium Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Selenium Injection
- Insulin aspart, recombinant Subcutaneous-Selenium Injection Solution
- Insulin aspart, recombinant Subcutaneous-Selenium Oral Drops
- Selenious Acid-Insulin degludec
- Selenious Acid-Insulin Degludec (U-100) Prefilled Pens
- Selenious Acid-Insulin Degludec (U-100) Vials
- Selenious Acid-Insulin Degludec (U-200) Prefilled Pens
- Selenious Acid-Insulin degludec and liraglutide
- Selenious Acid-Insulin degludec and liraglutide Subcutaneous